CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shield Therapeutics PLC Company Snapshot
Shield Therapeutics PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shield Therapeutics PLC with three other companies in this sector in the United Kingdom: Vernalis Plc (2018 sales of £11.48 million [US$14.89 million] of which 76% was Research and development), MaxCyte Inc (£12.53 million [US$16.25 million] of which 100% was Medical Service), and Tissue Regenix Group PLC (£11.62 million [US$15.07 million] of which 55% was Orthopaedics).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shield Therapeutics PLC
  Stock Performance Chart for Shield Therapeutics PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 182.50p
(Figures in Pounds Sterling)
1 Week 0.6%   13 Weeks -1.1%  
4 Weeks 73.0%   52 Weeks 453.0%  
 
Shield Therapeutics PLC Key Data:
  Ticker: STX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 11,881,000
(Year Ending Jan 2019).
Employees: 15
  Currency: Pounds Sterling Market Cap: 213,869,299
  Fiscal Yr Ends: December Shares Outstanding: 117,188,657
  Share Type: Ordinary Closely Held Shares: 99,552,933
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.